This is an old revision of this page, as edited by 139.127.253.7 (talk) at 14:36, 28 July 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:36, 28 July 2011 by 139.127.253.7 (talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Names | |
---|---|
IUPAC name (3R,4R,4aR,6aS,8R,9R,11aS,11bS)-4,9-bis(hydroxymethyl)-4,11b-dimethyltetradecahydro-8,11a-methanocycloheptanaphthalene-3,9-diol | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.109.656 |
PubChem CID | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C20H34O4 |
Molar mass | 338.48 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
Aphidicolin is defined as a tetracyclic diterpene antibiotic with antiviral and antimitotical properties. Aphidicolin is a reversible inhibitor of eukaryotic nuclear DNA replication. It blocks the cell cycle at early S phase. It is a specific inhibitor of DNA polymerase B,D in eukaryotic cells and in some viruses and an apoptosis inducer in HeLa cells.
Natural aphidicolin is a secondary metabolite of the fungus Nigrospora oryzae.
References
- Dhillon VS, Husain SA, Ray GN (2003). "Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients". Teratog., Carcinog. Mutagen. Suppl 1: 35–45. doi:10.1002/tcm.10068. PMID 12616595.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)
This article about an organic compound is a stub. You can help Misplaced Pages by expanding it. |